Telemedicine Market to see Growth of 16.5% by 2022

marketresearchfuture

Market Research Future adds new report of “Global Telemedicine Market Research Report – Forecast To 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Key players profiled in the report are

  • Koninklijke Philips N.V. (The Netherlands)
  • Medtronic (Ireland)
  • AMD Telemedicine Technologies (U.S.)
  • General Electric Company (U.K.)
  • Neusoft Corporation (China)
  • McKesson Corporation (US)
  • Intel (US)
  • IBM (US)

Market Segmentation:

The global telemedicine market is segmented on the basis of type, which includes store and forward, remote monitoring, and real time interactive.

  • On the basis of Technology, the market is segmented into hardware, software, and services. The hardware technology is further segmented into on-site kiosks, telephone, and webcams. The Software technology is further segmented into mobiles apps. The Services are further segmented into consultation, online video conferencing, and academics.
  • On the basis of Application, the market is classified into telecardiology, telepsychiatry, teleradiology, telepathology, teledermatology, teleaudiology, teleopthalmology
  • On the basis of End Users, the market is segmented into hospitals, clinical, medical institutes

Market Highlights:

The global telemedicine market is experiencing massive growth across the globe on account of extensive use of healthcare IT solutions, improved telecommunication infrastructure, and high demand for primary care services across the globe. Furthermore, rising prevalence of chronic diseases and technological advancement in the healthcare fuel the market growth. High installation cost of telemedicine solutions and availability of internet services in rural areas may restrain the market growth.

The Global telemedicine market is expected to grow at a CAGR of 16.5% during the forecast period.

Study objectives:

  • To provide detail analysis of the market structure along with estimated future growth forecast for the next 5 years about various segments and sub-segments of the global telemedicine market.
  • To provide insights about factors affecting the market growth.
  • To analyze the global telemedicine market based on various factors – price analysis, supply chain analysis, Porters Five Force Analysis etc.
  • To provide country level analysis of the market with respect to the current market size and future growth prospect.
  • To provide country level analysis of the market’s segments which includes by type and by application.

Intended Audience

  • Global telemedicine  software manufacturers & suppliers
  • Contract research organizations (CROs)
  • Research and development (R&D) companies
  • Government research laboratories
  • Independent research laboratories
  • Government and independent regulatory authorities
  • Market research and consulting service providers
  • Academic institutes and universities

Regional Analysis

The global telemedicine market is segmented on the basis of regions: The Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounts is the leading player in the global  telemedicine market owing to an increasing demand for healthcare IT solutions, concentration of prominent market players, and availability of infrastructure for telemedicine.

Europe is experiencing a significant growth in the telemedicine market owing to the availability of funds from the Europe Union (EU) for telemedicine projects.

Asia Pacific shows phenomenal growth in telemedicine market and is expected to the fastest growing region as result of rising geriatric population and increasing prevalence of chronic diseases.

The Middle East & Africa also show a steady rise in the telemedicine market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Whipple’s Disease Market expected to reach USD 255.3 million by 2023

marketresearchfuture

Market Research Future adds new report of “Whipple’s Disease Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market:

  • AbbVie Inc. (US)
  • Allergan (Republic of Ireland)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Henry Schein Inc. (US),
  • Pfizer Inc. (US)

Market Segments:

The global Whipple’s disease market is segmented

  • On the basis of Diagnosis, which includes physical exam, biopsy, blood tests, polymerase chain reaction, endoscopy, and others. Biopsy plays important role in diagnosis of this disorder, these tests include needle biopsy, CT-guided biopsy, ultrasound-guided biopsy, aspiration biopsy (fine-needle aspiration), skin biopsy, surgical biopsy, and others. Blood tests sub-segmented into Complete blood count (CBC), Red Blood Cell Count (RBC), serum albumin test, total protein test
  • On the basis of Treatments, the market is segmented into medications, supplements, and others. Medications is sub-segmented into Intravenous (IV) ceftriaxone (Rocephin), Intravenous (IV) penicillin, sulfamethoxazole-trimethoprim, SMX-TMP, oxycycline (Vibramycin), hydroxychloroquine (Plaquenil), and others. Supplements include vitamin supplements, mineral supplements
  • On the basis of End User, it is segmented into hospitals & clinics, academic institutes, medical research centers

Market Highlight:

Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially,  the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes. Some common symptoms of this disease are weight loss, diarrhea, abdominal cramping and pain, weakness, fatigue, anemia, inflamed joints, and some other less common symptoms. The prevalence is one in one million people. The prevalence of this diseases is more in men than women.

Ongoing research and clinical trial to find effective cure drive the growth of market. Advancement in medical technology and increasing awareness about this disease boost the market growth.

The global Whipple’s disease market is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.

Intended Audience

  • Whipple’s Disease Diagnostic and Treatment Supplies Companies
  • Whipple’s Disease Diagnostic and Treatment Supplies Providers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Regional Analysis of the Global Whipple’s Disease Market   

The Americas holds the largest share in the global Whipple’s disease market. North American region, especially, the US dominates the market in this region. It is a rare disease and found in around less than one in million people in US. Some other factors such as advanced medical facilities, ongoing research and clinical trials, and availability of skilled health professionals. Increasing awareness about this disease in Latin America drives market growth in this region.

The new cases of this disease is increasing in Europe. Availability of advanced diagnostic and therapeutic options, high awareness among the European population, and availability of skilled medical professional drive the European market. Availability of cost-effective of treatment in East European countries, for instance,  Poland than the other parts of the region add fuel to the growing demand. Owing to availability of cost-effective treatment, patients from Western European countries and Russia travel to East and Central European countries to treat this disease.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

TMJ Disorders Market to Reach USD 1229.1 Million by 2023

marketresearchfuture

Market Research Future adds new report of “TMJ Disorders Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market:

  • AbbVie Inc. (US)
  • Allergan (Republic of Ireland)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Jubilant Cadista (US)
  • Pfizer Inc. (US)
  • Sun Pharmaceutical Industries Ltd. (India)

Market Segments:

The global TMJ disorders market is segmented

  • On the basis of Diagnosis, which includes physical exam, imaging tests, and others. Imaging tests plays important role in diagnosis of this disorder, these tests may include Computerized Tomography (CT) scan, X-rays, Magnetic Resonance Imaging (MRI), TMJ arthroscopy
  • On the basis of Treatments, the market is segmented into medications, therapies, surgical or other procedures, alternative medicine, and others. Medications is sub-segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others. Some therapies also help to cure this disorder such as Oral splints or mouth guards (occlusal appliances), physical therapy, counseling, and others. Some surgical or other procedures includes arthrocentesis, injections, TMJ arthroscopy, modified condylotomy, open-joint surgery, and others. Alternative medicine is also used for the treatment of this disorder such as acupuncture, relaxation techniques, biofeedback
  • On the basis of End User, it is segmented into hospitals & clinics, ambulatory surgery centers, academic institutes, medical research centers

Market Highlight:

TMJ disorders is commonly known as temporomandibular joint and muscle disorders. This is a medical condition which causes dysfunction and pain in the jaw joint and the muscles that control jaw movement. This medical condition is more common is women than men. According to the American Academy of Orofacial Pain, TMJ disorders may have more than one symptoms and causes. Some of the major symptoms of this disorder are aching facial pain, tenderness or pain in jaws, pain while chewing etc. TMJ disorders can occur if the joint’s cartilage is damaged by arthritis or by a blow or other impact or the disk erodes or moves out of its proper alignment.

Effective diagnosis can provide better treatment management of this disorder. Major diagnostic solution provider companies are engaged in developing and launching new medical imaging devices. Introduction and rapid adoption of advanced diagnostic devices are driving the market growth. Easy availability of medicines is another key driver for the market. Increasing demand for advanced diagnostic devices and treatment, especially from Asia and Latin America is driving the market growth.

The global TMJ disorders market is expected to grow at the CAGR of ~3.9% during the forecast period and is estimated to reach USD 1229.1 million by 2023.

Intended Audience

  • TMJ disorders Diagnostic and Treatment Companies
  • TMJ disorders Diagnostic and Treatment Service Providers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Regional Analysis of the Global TMJ disorders Market

The Americas dominate the global TMJ disorders market. According to National Institute of Dental and Craniofacial Research, approximately 10 million people are suffering from this disorder in the US alone. North America region, especially US is the dominating country in this market due to various reasons such as advanced medical facilities, ongoing research and clinical trials related to TMJ disorder, and availability of skilled health professionals. In Latin American countries, awareness of this disorder is growing which is driving the market growth in this region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Metastases Spinal Tumor Market to Register at 3.2% by 2023

marketresearchfuture

Market Research Future adds new report of “Metastases Spinal Tumor Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market:

  • Hoffmann-La Roche Ltd (Switzerland)
  • Amgen Inc. (US)
  • Novartis AG(Switzerland)
  • Abbott (US)
  • Beckman Coulter Inc. (US)
  • Debiopharm Group (Switzerland)
  • AbbVie Inc. (US)
  • Bayer AG (Germany)

Market Segments:

The global metastases spinal tumor market is segmented

  • On the basis of Type, which comprise extradural, metastatic spinal tumors of the bone
  • On the basis of Diagnosis, this market is segmented into laboratory tests, imaging tests, biopsy, and others. Imaging tests includes X-Ray, Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI scan), Angiography, F-18 fluorodeoxyglucose positron emission tomography, and others. Biopsy is sub-segmented into percutaneous needle biopsy, open incisional and excisional biopsy
  • On the basis of Treatments, the market is segmented into non-operative treatment, surgical treatment, and others. Non operative treatment is sub-segmented into medications, radiation therapy, ablation, chemotherapy, and others. Medications includes anti-inflammatory drugs, narcotics (opioids), corticosteroids, rankl inhibitors and bisphosphonates, and others. Ablation is further sub-segmented into radiofrequency ablation, cryoablation, and others. Surgical treatment is further sub-segmented into minimally invasive surgery, open surgery, and others. Minimally invasive surgery is sub-segmented into vertebral fracture treatments, transarterial chemoembolization, and others. Vertebral fracture treatments is further sub-segmented into vertebroplasty, kyphoplasty (vertebral augmentation), and others. Open surgery includes spinal stabilization surgery, spinal decompression surgery
  • On the basis of End User, it is segmented into hospitals & clinics, ambulatory surgery centers, academic institutes, research centers

Market Highlight:

Metastases spinal tumor is one of the most common problems in oncology. Approximately 5%-10% of the cancer patients face spinal metastases disease. Most of the metastatic spinal tumors are developed outside the dura (extradural). Around 70% of the spine tumors occur in the thoracic region, while 20% in the lumbar, and 10% in the neck region. Some of the common symptoms of metastases spinal tumor are back pain, tingling or numbness, and weakness.

Early diagnosis can provide better treatment management of this disorder. Major diagnostic solution provider companies are engaged in developing and launching new medical imaging devices. Introduction and rapid adoption of advanced diagnostic devices are driving the market growth. Increasing research, clinical trials, and new solution development in the field of oncology drive the market. Additionally, growing demand for diagnostic devices and treatment from emerging markets of Asia and Latin America add fuel to the growth of the market.

The global metastases spinal tumor market is expected to grow at the CAGR of ~3.2% during the forecast period and is estimated to reach USD 1547.8 million by 2023.

Intended Audience

  • Metastases Spinal Tumor Diagnostic and Treatment Supplies Companies
  • Metastases Spinal Tumor Diagnostic and Treatment Supplies Providers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Dental Amalgam Market is expected to Rise at CAGR of 5% by 2023

marketresearchfuture

Market Research Future adds new report of “Dental Amalgam Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Key players profiled in the report are

  • DMP dental
  • Patterson dental
  • APL Materials
  • DMP
  • Nanjing FoiNoe Co. Ltd.
  • AT&M Biomaterials Co. Ltd.
  • BOME
  • Kerr Corporation
  • Benco Dental Supply Company
  • Henry Schein Inc.

Market Segments:

The global dental amalgam market is segmented on the basis of particle shape, particle size, metals and number of alloy metals.

  • Based on Particle Shape, the market has been segmented as lath cut particles, spherical particles and admixed particles
  • Based on the particle size, the market has been segmented as micro cut, fine cut and coarse cut.
  • Based on the Metals, the market has been segmented as noble metals (gold, silver, and other), non-noble metals (copper, gallium, others)
  • Based on the Number Of Alloy Metals, the market has been segmented as binary alloy, ternary alloy and quaternary alloy

Market Highlight:

Dental amalgam are alloys consisting of liquid mercury and metal alloy of copper, zinc, silver, gold etc. which are used to fill cavities caused by tooth decay.

The market drivers for dental amalgam include rising cases of tooth decay caused by rise of risk factors such as high sugar diets, fast foods, sedentary lifestyles etc. The development of high quality corrosion resistant and stronger amalgams with better aesthetic qualities is also driving the market. The market restraints are development of broad spectrum antibacterial toothpastes and mouth washes, better hygiene standards etc.

Considering all these factors the market for dental amalgam is expected to reach $ 500 million by the end of 2023, this market is projected to growing at a CAGR of ~ 5 % during 2017-2023.

Intended Audience

  • Global dental amalgam, manufacturers & suppliers
  • Research and development (R&D) companies
  • Market research and consulting service providers
  • Academic institutes and universities

Study objectives:

  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next 6 years about various segments and sub-segments of the global dental amalgam market.
  • To provide insights about factors affecting the market growth.
  • To analyze the global dental amalgam market based on various factors – Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.
  • To provide country level analysis of the market with respect to the current market size and future growth prospects.
  • To provide country level analysis of the market which includes segmentation by particle shape, particle size, metals and number of alloy metals.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Cystic Fibrosis Market 2022 – Key Futuristic Trends and Opportunities

marketresearchfuture

Market Research Future adds new report of “Cystic Fibrosis Market Research Report – Global Forecast To 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are:

  • Vertex Pharmaceuticals
  • Hoffmann-La Roche
  • AbbVie
  • Gilead Sciences
  • Novartis
  • Genentech
  • Pharmaxis
  • Chiesi Farmaceutici
  • Forest Laboratories

Market Segments:                

Cystic fibrosis market has been segmented

  • On the basis of Diagnostic Test which comprises of immunoreactive trypsinogen (IRT) test, sweat chloride test, sputum test, chest X-ray, CT scan and pulmonary function test
  • On the basis of Treatments, market is segmented into medical therapy, surgical treatment
  • On the basis of Drug Type, market is segmented into small molecules and biologics

Market Highlight:

Cystic fibrosis is a genetic condition that causes severe damage to the respiratory and digestive systems. The damage is often caused due to buildup of thick, sticky mucus in the organs. The most commonly affected organs by cystic fibrosis are lungs, pancreas, liver and intestines. Every year, approximately 1000 people are diagnosed with this serious condition in United States. Globally the market for cystic fibrosis is increasing rapidly. Globally the market for cystic fibrosis is expected to grow at the rate of about from 2016 to 2022.

Study objectives of Cystic Fibrosis Market:

  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the cystic fibrosis market
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by diagnostic test, by treatment, by drug type and its sub-segments.

Intended Audience:

  • Cystic fibrosis manufacturers & suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Academic Institutes and Universities

Regional Analysis of Cystic Fibrosis Market:               

Globally North America is the largest market for cystic fibrosis. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for cystic fibrosis.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

Drug of Abuse Testing Market to see Growth Rate of 5.3% by 2020

marketresearchfuture

Market Research Future adds new report of “Drug of Abuse Testing Market Research Report- Global Forecast to 2020” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are:

  • Roche Holding Limited
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings
  • Alere Inc.
  • Abbott Laboratories
  • Randox Laboratories Ltd
  • Psychemedics Corporation
  • Bio-Rad Laboratories Inc.
  • Sonic Healthcare
  • Thermo Fisher Scientific Inc.

Key Finding:

  • The global drug of abuse testing market is expected to reach $3.0 billion in 2020, mainly driven by increased use of illicit drugs and need of drug abuse testing at organizational level.
  • Onsite testing market is more than double the size of laboratory testing due to ease of use, cost effectiveness and immediate results.
  • Urine followed by saliva is the most common specimen used in the drug of abuse testing. Hair as a specimen is also becoming a more effective way for testing long term drug use.
  • North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market

Market Segments:

Global drug of abuse testing market is mainly segmented into test type and samples.

  • On the basis of Test Type is segmented into onsite screening test and laboratory drug testing
  • On the basis of Samples the market is segmented into urine, hair, saliva

Market Highlight:

Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they’re not a diagnostic test for addiction. These tests may be used for monitoring treatment. The factor which may influence the growth of the drug of abuse testing market is increased use of drug testing at organizational level, increased production and trade of illicit drugs worldwide and others. Globally the market for drug of abuse testing is expected to grow at 5.3% GAGR from 2016 to 2020.

Intended Audience

  • Drug of abuse testing companies
  • Drug of abuse testing reagent Manufacturers
  • Hospitals and Clinics
  • Diagnostics Centers
  • National Organizations & Government Organizations
  • Academic research institutes
  • Government institutes

Study Objectives of the Market:

  • To provide detailed analysis of the market structure along with forecast for the next 9 years of the various segments and sub-segments of the drug of abuse testing market
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide forecast revenue of the market segments and sub-segments with respect to the main geography and various regions globally.
  • To provide regional level analysis of the market with respect to the current market size and future prospective
  • To provide regional level analysis of the market for segments by test type, by sample and its sub-segments.

Regional Analysis of Drug of Abuse Testing Market:   

Globally Americas is the largest market for drug of abuse testing market. Europe is the second-largest for drug of abuse testing market. Europe drug of abuse testing market is expected to grow with a steady pace.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

Lancet Industry: Future Demand, Market Analysis & Outlook to 2022

Market Research Future adds new report of “Global Lancet Market Research Report- Forecast To 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the Key Players in This Market Are:

  • Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Greiner Bio One International GmbH
  • Improve Medical Technology Co. Ltd
  • Terumo Medical Corporation
  • Bayer Cropscience Limited
  • HTL-STREFA S.A
  • Sarstedt AG & Co

Key Findings:

  • The Global Lancets Market and is expected to reach USD 2,882.6 million by 2022
  • Regionally, North America holds the largest market share of global Lancets Market and is expected to grow at a CAGR of 11.2% during the forecast period from 2016-2022
  • On the basis of type, safety lancets accounts the largest market share in 2015 and is expected to reach USD 2,061.8 million by 2022.

Market Segments:

Global Lancet market has been segmented

  • On the basis of Types which comprises of personal, safety
  • On the basis of End Users which consists of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics

Market Highlight:

A blood lancet, or simply a lancet, is small therapeutic equipment utilized for blood testing utilized for various blood sampling applications. A blood lancet is a surgical tool with a two-fold edged or sharp edge needle. Lancets are utilized to make vein punctures, for example, a finger stick, to obtain small blood samples and are generally disposable.

Safety lancets are single-use gadgets/devices for narrow blood testing used by professionals in healthcare services. They are a necessary part to the sharps-injury aversion programs in hospitals, clinics, research centers, physicians’ offices and wherever both patients and experts need to feel safe. Needle-stick wounds and diseases can be avoided by utilizing Safety lancets.

Globally lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues and many other issues. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients.

The global market of lancets is growing rapidly because of the rising prevalence of diabetes and growing number of blood borne diseases across the globe. The global market of lancets is expected to reach USD 2,882.6 million in 2022 and is expected to grow with a CAGR of approximately 11.3% during the forecast period.

Study Objectives of Lancet Market:

  • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Lancet market
  • To provide insights about factors affecting the market growth
  • To analyze the Lancet market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by type, by end users and its sub-segments

Intended Audience

  • Lancet manufacturers
  • Lancet Suppliers
  • Pharmaceutical companies
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities

Regional Analysis of Lancet Market:

Globally North America is the largest market for Lancet. The North American market for Lancet is expected to grow at a CAGR of 11.2% during the forecasted period. This is due to increasing prevalence of diabetic patients. Europe is the second-largest market for Lancet with the market value of USD 592.8 million in 2015. Whereas Asia pacific is expected to be a growing market for Lancet market and expected to grow at a rapid rate.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Tonsil Cancer Market to cross USD 3396.3 Million by 2023

Market Research Future adds new report of “Tonsil Cancer Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market:

  • Hoffmann-La Roche Ltd (Switzerland)
  • Amgen Inc. (US)
  • Novartis AG (Switzerland)
  • Abbott (US)
  • Beckman Coulter Inc. (US)
  • Debiopharm Group (Switzerland)
  • AbbVie Inc. (US)
  • Bayer AG (Germany)

Market Segments:  

The global tonsil cancer market is segmented

  • On the basis of Type, which comprises squamous cell carcinoma, salivary gland cancer, lymphoma, mucosal melanoma, sarcomas, malignant fibrous histiocytoma, Peripheral Neuroectodermal Tumor (PNET), and others. Sarcomas is further sub-segmented into chondrosarcoma, liposarcoma, synovial sarcoma
  • On the basis of Diagnosis, the market is segmented into physical exam, imaging tests, removing a sample of tissue for testing, and others. Imaging tests is further sub-segmented into Computerized Tomography (CT), Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)
  • On the basis of Treatments, the market is segmented into surgery, radiation therapy, chemotherapy, rehabilitation, and others. Surgery is further sub-segmented into transoral surgery, transoral robotic surgery, open surgery, reconstructive surgery, and others. Radiation therapy includes external beam radiation therapy, internal radiation therapy, and others. Chemotherapy is further sub-segmented into alkylating agents, plant alkaloids, antitumor antibiotics, antimetabolites, topoisomerase inhibitors, miscellaneous antineoplastics
  • On the basis of End User, it is segmented into hospitals & clinics, medical research centers, academic institutes

Market Highlight:

Tonsil Cancer is a type of head and neck cancer which develops in the parts of throat and just behind the mouth. Tonsil cancer is also known as the cancer of oropharynx. One of the common symptoms of tonsil cancer is sore throat while some other symptoms are fatigue, hoarseness or a change of voice while speaking, ear pain, bleeding from your mouth, and weight loss. People who drink and smoke have almost double chances of tonsil cancer. Many times tonsil cancer is connected with a virus associated with sexual contact known as human papillomavirus (HPV).

Increasing incidence of tonsil is major driver for the market while other factors such as increasing awareness about this disorder, the introduction of the new treatment or therapies and rising demand from emerging markets of Asia as well as Latin America drives the growth of the global market. New research to cure tonsil cancer is another key driver for the market. The global tonsil cancer market is growing moderately and is expected to continue its growth over the forecast period.

The global tonsil cancer market is expected to grow at the CAGR of ~4.6% during the forecast period and is estimated to reach USD 3396.3 million by 2023.

Intended Audience

  • Tonsil Cancer Diagnostic and Treatment Supplies Companies
  • Tonsil Cancer Diagnostic and Treatment Supplies Providers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Regional Analysis of the Global Tonsil Cancer Market 

The Americas dominate the global market for the tonsil cancer. North American countries like US dominates the market while Latin America region is also growing significantly in this region. The US is one of the top revenue generating countries in the global tonsil cancer treatment. Increasing number of patients with tonsil cancer is major driver for this market. North America is holding major market share due to some major factors like easily available treatment facilities, extended insurance cover, and adoption of advanced therapies to cure tonsil cancer.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Drug Allergy Market to Reach USD 4764.0 million by 2023

Market Research Future adds new report of “Drug Allergy Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market:

  • AstraZeneca (UK)
  • Bayer (US)
  • Circassia (US)
  • HAL Allergy Group (the Netherlands)
  • Johnson & Johnson Services Inc. (US)
  • MAGNA Pharmaceuticals Inc. (US)
  • Stallergenes Greer (UK)

Market Segments:

The global drug allergy market is segmented

  • On the basis of Type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance
  • On the basis of Diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test
  • On the basis of Treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide
  • On the basis of End User, it is segmented into hospitals & clinics, medical research centers, academic institutes

Market Highlight:

Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.

Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.

The global drug allergy market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Intended Audience

  • Drug Allergy Diagnostic and Treatment Supplies Companies
  • Drug Allergy Diagnostic and Treatment Supplies Providers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Regional Analysis of the Global Drug Allergy Market    

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com